CordenPharma inks AmbioPharm buyout to continue peptide production expansion
BioSpace
Swiss service provider CordenPharma is acquiring AmbioPharm, gaining facilities such as a plant in South Carolina to provide a fully U.S.-based supply.
pharminent
June 1, 2026 (Last updated: June 1, 2026)
BioSpace
Swiss service provider CordenPharma is acquiring AmbioPharm, gaining facilities such as a plant in South Carolina to provide a fully U.S.-based supply.